Areas of Care

Clinical Trials Advanced Cutting Edge Treatment

Scroll down for a Complete Listing of our Current Trials and Information on Eligibility.

Promising New Treatments From the Best in Cancer Care

At East Jefferson General Hospital, our mission is to offer the best cancer care in our region. Part of fulfilling this mission is offering our patients access to a broad range of clinical trials.

Clinical trials allow our patients access to some of the most advanced and cutting edge treatments available. Our patients who choose clinical trials have the opportunity to receive promising new treatments or the best, most up-to-date standard treatments. Answers gained from clinical trials can help not only you or your loved one, but also cancer survivors all over the world.

Please review the database of clinical trials available at East Jefferson General Hospital – we have created this as a resource for cancer patients in our region.

If you or a loved one is interested in a particular trial, please send us an inquiry. Your inquiry will be passed on to the appropriate physician, who will discuss – with you and with your oncologist – whether the trial is the right choice for you.

Warm regards,
Sidd Padmanabha, M.D.
EJGH Cancer Center

(c) Sidd Padmanabha and Jefferson Radiation Oncology, 2018.

EJGH Trials Send us an Inquiry


FAQs and Glossary

  • Frequently Asked Questions

    What is a cancer clinical trial?
    A cancer clinical trial is a research project that aims to see whether an investigational drug or treatment is effective and safe.

    What are the advantages of enrolling in a clinical trial?
    Advantages to enrolling in a clinical trial may include: (1.) The ability to get early access to a new medication or treatment, often before they are more widely available; (2.) the opportunity to choose a treatment approach that is aligned with your goals; and (3.) and the chance to make an important contribution to future patients like yourself by helping us all learn about what treatments are most effective and offer the best quality of life.

    How do I know whether I can enroll clinical trial?
    All clinical trials have inclusion criteria, guidelines about who can and cannot participate. Please contact us if you are interested in a certain clinical trial, and we can discuss whether you meet inclusion criteria. If you are interested in a clinical trial, we recommend that you discuss this with your cancer doctor (quite likely, your oncologist) and other physicians before enrolling.

    How safe is a clinical trial?
    All clinical trials are evaluated by a team called the Institutional Review Board (also known as the “IRB”. The IRB helps to ensure that the treatment program offered is reasonably safe. The IRB often consists of doctors, nurses, scientists, and other experts in the field. Treatments and drugs used in clinical trials have often been studied for years in the laboratory and, generally, in both animals and humans before they become available to clinical trial participates. Patients who are on a clinical trial are carefully assessed by their health care team for not only efficacy but also for evidence of side effects on an on-going basis, usually until the end of the clinical trial. While to measures discussed above are designed to protect patients, there is always some level of risk. The risks and benefits of any clinical are discussed in plain English in your consent form. It is important that you understand these before enrolling.

    Will the research help me personally? Will I get a “sugar pill”?
    A clinical trial may give you the opportunity to try an emerging treatment or drug, often before it is widely available. While the clinical trial may give you this opportunity, it does not guarantee this opportunity. In some trials, patients can be randomly assigned to the control group, the group that gets standard, currently-used therapies. Please keep in mind that patients in the control group often get the best known currently-used therapy. In some cases, when there is no known useful therapy, patients in the control group may receive a placebo.

    How will I know about the benefits and risks?
    It is important to know the potential risks and benefits of any clinical trial. These are listed in a portion of the protocol known as the “informed consent”. Please ask all questions that you may have and be sure that you understand the treatment protocol

    What if I change my mind?
    You give your consent to go forward with any clinical trial before enrolling. Should you later change your mind, it is your right to drop out.

    Where can I find out about more about clinical trials?
    There is a large database of clinical trials offered all around the country at the National Institute of Health Website. You can reach this at For the benefit of out patients, our website EJGH Clinical Trials lists all clinical trials being offered at the EJGH campus.

  • Glossary

    Adjuvant: an Adjuvant therapy is an extra or additional therapy that is used after the primary therapy. It is often used to improve upon the cure rate and decrease the rate of occurrence. An example, for instance, is when adjuvant radiation or adjuvant Tamoxifen is given after surgery for breast cancer — both these extra therapies after the main therapy cut the recurrence risk.

    Antibody: a complex molecule that the human body uses to recognize certain proteins. Drugs using antibodies can often target tumor cells very specifically, having relatively little effects on other healthy tissues. Herceptin ® is an example of an antibody-based drug

    Biologic: Biologics are a certain type of chemotherapy that usually act upon a very specific step in the biology of the cancer. Biologics are made from biologic processes that are adapted to treat a disease. Biologics include drugs made of DNA, RNA, or proteins. Herceptin is an example of a biologic.

    Blinded/ Double-Blind: a Blinded study is a multiple-arm study in which the patient and, usually, the investigator do not know which arm the patient is in. Studies that are blinded provide great data because the patient or the doctor cannot influence the results.

    Chemotherapy: chemotherapy is a medicine that is used to treat cancer, usually by killing cancer cells or preventing cancer cells by growing. Chemotherapy can be used for cure or palliation. It is generally given intravenously (IV) or by mouth (orally).

    Hormone Therapy: Hormone therapy involves giving a drug that manipulates a patient’s hormonal levels of treat a cancer. The hormone therapy is often given orally (such as Arimidex) but can also be intravenously (such as Faslodex) or intramuscularly (such as Lupron.) Breast cancer and prostate cancer are often treated with hormonal therapy.

    Neoadjuvant: a neoadjuvant is a form of an adjuvant therapy, a therapy that is an extra or additional therapy to the primary therapy. Rather than given after the primary therapy, it is given before the primary therapy. Examples are breast cancer, in which chemotherapy can be given before surgery, or rectal cancer, in which chemoradiation can be given before surgery.

    Non-small Cell Lung Cancer (NSCLC): this is the most common form of lung cancer. Lung adenocarcinomas and squamous cell carinomas fall into this group.

    Melanoma: this is a cancer arising from specialized skin cells called melanocytes.

    Phase I or Phase II: these are the phases when first the safety and the optimal efficacious dose is determined. 

    Phase III: This is among the final phases in assessing a new drug or treatment. In this phase, the efficacy or effectiveness of a drug is determined by comparing it directly to the standard arm.

    Placebo-Controlled: this is a type of a Phase III trial in which the experimental arm (the new drug or treatment) is compared against a placebo. This allows careful evaluation of the effect of the experimental treatment.

    Radiation Therapy: this is the use of precise, high-energy X-rays that can be directed at a tumor or at an area at risk of cancer spread. Radiation therapy can be used to cure cancer, such as in the case of prostate cancer or head and neck cancer, or to palliative or improve upon symptoms such as pain.

    Randomized: a randomized trial is one in which some participants are given one treatment and others a different treatment, often on a random basis. This allows doctors and scientists to directly compare the two treatments.

    Small Cell Lung Cancer: a form of lung cancer, less common than small cell lung cancer.

    Vaccine: this is a treatment that recruits the body’s own immune system to fight a tumor.

  • Disclaimer

    This website is only for the purpose of sending an inquiry about a clinical trial. Your contact information will be passed our clinical trial coordinators who will pass on your contact information to the physician’s office that is sponsoring the trial that you are interested in. Entry into any clinical trial is not guaranteed – reasons for this include but are not limited to the fact that you may not be eligible, the trial may be completed or closed, or the possible treatments may not be indicated or appropriate for you.

    We will attempt to contact you via your inquiry within (5) five business days, however, we cannot guarantee that you will be contacted. Though we update this website several times a year, there may be clinical trials that are not on this list or trials on this list may have closed.

    This website is not designed to give medical advice, and does not take the place of your physician. If you have an urgent medical matter, please contact your physician or call emergency medical services.

    (c) Sidd Padmanabha, M.D., and Jefferson Radiation Oncology, 2018.


Contact Us

Please use the Inquiry form above or email us directly at